Volume 9, Number 6—June 2003
Dispatch
Laboratory Surveillance of Dengue in Argentina, 1995–2001
Table 1
Year | MAC-ELISAb | PRNTb | HIb | Viral isolates + ampliconsb | DENV serotypec | Totalb by all techniques |
---|---|---|---|---|---|---|
1995 |
0/18 |
ND |
ND |
ND |
– |
0/18 |
1996 |
0/28 |
ND |
ND |
1/1 |
DENV-3 |
1/28 |
1997 |
4/16 |
2/4 |
ND |
ND |
– |
4/16 |
1998 |
22/64 |
14/17 |
ND |
ND |
DENV-1,2 |
27/68 |
1999 |
17/37 |
12/12 |
ND |
0/2 |
DENV-1 |
23/45 |
2000 |
142/307 |
9/10 |
43/44 |
19/31 |
DENV-1 |
162/279 |
2001 |
9/9 |
3/3 |
2/2 |
ND |
– |
9/39 |
Total | 194/479 | 40/46 | 45/46 | 20/34 | – | 226/493d |
aDENV, dengue fever virus; MAC-ELISA, immunoglobulin M antibody capture enzyme-linked immunosorbent assay; PRNT, plaque reduction neutralization test; HI, hemagglutination inhibition test; ND, not done.
bPositive/tested.
cIn most cases, the serotype was determined only by serologic testing unless we indicate otherwise that virus isolation or polymerase chain reaction was also used. In many of these cases, the serotype could not be determined because of cross-reactions in serologic tests.
dSome samples were tested by one technique, and others were tested by two or more techniques; therefore, these numbers do not represent the total obtained by adding the rows.
Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.